Sort by
Keyphrases
Diabetic Cardiomyopathy
100%
Interleukin-6
100%
Cardiomyocytes
87%
Free Fatty Acids
25%
Insulin Resistance
25%
NF-B
20%
Molecular Mechanism
20%
High-fat Diet Consumption
16%
Fibrosis
16%
Heart Failure with Preserved Ejection Fraction (HFpEF)
16%
Diastolic Dysfunction
16%
Plasma Free Fatty Acids
16%
Patients with Obesity
12%
Inflammation
8%
Mouse Model
8%
Left Ventricular Hypertrophy
8%
Local Cells
8%
Adipose Tissue
8%
Monocyte Chemoattractant protein-1 (MCP-1)
8%
Hypertrophy
8%
Loss Function
8%
Myocardial Dysfunction
8%
Diabetic Patients
8%
Cardiac Dysfunction
8%
Metabolic Syndrome
8%
Endothelial Cells
8%
Obesity
8%
Interleukin-1β
8%
Systemic Inflammation
8%
Cell-to-cell
8%
Novel Therapeutic Targets
8%
Heterodimer Formation
8%
Novel Mechanism
8%
Local Mechanisms
8%
Specific Loss Power
8%
Paracrine Factors
8%
Type 2 Diabetes Mellitus (T2DM)
8%
IL-6 Promoter
8%
Pharmacology, Toxicology and Pharmaceutical Science
Peroxisome Proliferator Activated Receptor
100%
Diabetic Cardiomyopathy
100%
Interleukin 6
100%
Fatty Acid
38%
Heterodimer
23%
Insulin Resistance
19%
Fibrosis
15%
Inflammation
15%
Diastolic Dysfunction
15%
Heart Failure with Preserved Ejection Fraction
15%
Cytokine
11%
Metabolic Syndrome X
7%
Mouse Model
7%
Tumor Necrosis Factor
7%
Heart Left Ventricle Hypertrophy
7%
Chemokine
7%
Diabetes Mellitus
7%
Non Insulin Dependent Diabetes Mellitus
7%